Commentary By Josh Remick, PGY-2
In the December 27th 2006 issue of JAMA, Yang et al. reported the results of a nested case-control study of United Kingdom patients entitled “Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture.” …
Commentary By Josh Remick, PGY-2
In the December 27th 2006 issue of JAMA, Yang et al. reported the results of a nested case-control study of United Kingdom patients entitled “Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture.” …
The best online dermatology atlas I have come across is dermIS.net. The site originates from Germany and includes an excellent, easily searchable database with terrific pictures and clinical information. The most useful feature of the site however is the differential diagnosis …
A 53 year old male with chronic hepatitis C and type 2 diabetes is found to have a moderately elevated cholesterol.
1. Is it safe to start a statin?
2. Do statins have any effect on viral replication?
Comentary By Ed Bini, M.D. Associate …
A 58 year old man with type 2 diabetes and chronic venous insufficiency/recurrent lower extremity cellulitis presents with fever and a left lower extrmity ulcer with purulent drainage. He’s been successfully treated in the past with both Unasyn/Augmentin or …
Commentary By Michael Poles, M.D. Gastroenterologist, Assistant Professor of Medicine, Mircrobiology and Pathology.
Every once in a while I will be feeding this new blorganism (or is it bloganism?) with content from the world of gastroenterology. Today I …
Clinical Correlations will be closed for the holiday weekend. We will resume posting on Tuesday January 2nd, 2007. I just wanted to take this opportunity to thank everyone who's been involved and contributed to making the inauguration of Clinical Correlations so successful. …
A 57 year old female with a past medical history of hypertension, obesity, remote intravenous drug use and several years of chronic low back pain, with both intermittent radiation to her lower extremities and decreased sensation in her …
Commentary By: Minisha Sood PGY-3
The FDA has received reports of 90 patients with moderate to end-stage kidney disease who have undergone MRI or MRA with a gadolinium-based contrast agent and subsequently developed a new disease known as Nephrogenic …